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ABSTRACT 
Objective: The objective of present research work was to formulate and evaluate a novel oral edible gel dosage form using gellan gum as gelling 
agent and carvedilol as a model drug to ease the administration to dysphagic and geriatric patients.  
Methods: Oral edible gels were prepared using gelling agent low acetylated gellan gum and sodium citrate in different concentrations. The prepared 
edible gel formulations were evaluated for gelation time, appearance, texture, viscosity, pH, syneresis, drug-excipient compatibility studies by 
fourier transform infrared FTIR and percentage of drug release from the gel formulation.  
Results: Formulation containing gellan gum (0.4 % w/v) and sodium citrate (0.3 % w/v)) was found to be “spoon thick” in consistency that is 
accepted for dysphagic patients as per national dysphagia diet task force. This formulation showed more than 95 % drug release within 12 min and 
found to be stable for 6 mo. All other parameters tested were optimal. Hence, this formulation was considered optimized.  
Conclusion: From this study, it can be concluded that the novel edible gel dosage form containing Carvedilol can be formulated and this dosage 
form may prove to be more efficacious in the treatment of hypertension in dysphagic patients. 
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Dysphagia is a clinical syndrome where patients ability to swallow solids 
or liquids decreases drastically [1]. It is been reported in the studies that 
over 6 million adults suffer from dysphagia [1]. It can be seen in any age 
groups but it is increasingly seen in old age and associated diseases like 
Parkinson’s disease, Neck cancer and hypertension [2].  
The oral route of drug administration is most preferred by the 
patients and doctors because of its ease of administration, painless 
and enhanced patient compliance. However, patients suffering from 
dysphagia experience difficulty in swallowing with existing oral 
dosage forms like tablets and capsules. Administration of liquid 
dosage forms may result in choking in these patients [3]. Moreover, 
elderly patients cannot easily take tablets or capsules. The physical 
injury caused upon rubbing of the solid preparation against mucous 
membrane in the oral cavity can discomfort the patient [3]. The 
crushing of modified release tablets is undesirable, as this may lead 
to drug toxicity or loss of efficacy of the dosage form [4].  
Carvedilol (CDL) is an oral, cardio selective β-receptor blocking 
agent, primarily used to treat hypertension [4]. It undergoes 
extensive first pass hepatic metabolism due to cytochrome P450 
2D6 (CYP2D6) enzymes and its oral bioavailability is only 25-35%. 
Half life also varies extensively from 7 to 10 h. The recommended 
daily dose of CDL is 3.125 mg. Depending on the blood pressure (BP) 
of the patient and tolerance, dose may be increased slowly to a 
maximum of up to 25 mg daily [5]. 
Thickened liquids play a vital role in reducing the risk of aspiration 
for dysphagic patients. Previous studies have indicated the 
importance of viscosity as a bolus variable during the swallowing 
process [6, 7]. Dietary professionals and the speech-language 
pathologists determine the appropriate liquid dosage form 
consistencies for each patient [8, 9]. In 2002, the american dietetic 
association established the national dysphagia diet (NDD) guidelines 
for thickened dietary supplements [10]. To ensure safety during oral 
drug administration, patients with dysphagia require an appropriate 
oral dosage form or modification of the existing dosage form. 
To address the above problem, we formulated and evaluated an 
edible gel (EG) dosage form using gellan gum as a gelling agent and 
carvedilol as a model anti-hypertensive drug. 
MATERIALS AND METHODS 
Materials 
Carvedilol was obtained as gift sample from Chandra labs, 
Hyderabad, India. Gellan gum was gift sample from Mylan 
laboratories ltd, Hyderabad, India. PEG 400, citric acid, mannitol, 
methyl paraben, were purchased from ESSEL fine chem., Mumbai, 
India. Strawberry flavour was purchased from Robin chemicals, 
Mumbai. Sucralose was obtained from J. K. Suralose Inc. Ltd., Delhi. 
All other ingredients used were of analytical reagent grade.  
Methods 
Formulation of oral edible gel 
All the ingredients were passed through ASTM sieve # 60 and weighed 
accurately. The details of the composition are shown in table 1. Gellan 
gum powder was dispersed in 50 ml of distilled water maintained at 
95 °C and stirred using magnetic stirrer (Remi PMDC, Mumbai, India). 
Stirring was continued for 20 min to facilitate the hydration of the 
gellan gum. The weighed quantity of the mannitol was added to the 
above dispersion with continuous stirring. The drug carvedilol was 
then added to it under stirring. Citric acid, methyl paraben were added 
and mixed. Sodium citrate was separately dissolved in 10 ml distilled 
water and added to the mixture. Strawberry flavor was added at last 
when the temperature reached below 40 °C. Weight of the gel was 
adjusted finally to 100 gm with distilled water. The mixture was 
allowed to cool to room temperature to form gel. The edible gel 
formulations were prepared using five different concentrations of 
gellan gum (0.1, 0.2, 0.3, 0.4 and 0.5 % w/v), each with two different 
sodium citrate concentrations (0.3 and 0.5 % w/v) [11]. 
Evaluation of oral edible gel 
Oral edible gels were subjected to various evaluation parameters. 
Determination of gelation time 
Gelation time was determined by placing the prepared gel 
formulations in 20 ml flat bottomed cylindrical vial maintained at 
room temperature. The gelation time was considered as the time taken 
for the formulation to convert from “sol” state to “gel” state [12]. 
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Table 1: Formulation of oral edible gel 
Ingredients Formulations 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
Carvedilol (mg) 250 250 250 250 250 250 250 250 250 250 
Gellan gum (%) 0.1 0.1 0.2 0.2 0.3 0.3 0.4 0.4 0.5 0.5 
Sodium citrate (%) 0.3 0.5 0.3 0.5 0.3 0.5 0.3 0.5 0.3 0.5 
PEG 400 (%) 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Citric acid (%) 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 
Mannitol (%) 30 30 30 30 30 30 30 30 30 30 
Sucralose (%) 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 
Methyl paraben (%) 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Strawberry (%) 2 2 2 2 2 2 2 2 2 2 
Water (% w/w) up to 100 100 100 100 100 100 100 100 100 100 
PEG=Polyethylene glycol           
  
Appearance and texture evaluation of the gel 
The texture of the formulated gels was evaluated in terms of 
stickiness and grittiness by mildly rubbing the gel between two 
fingers [13]. The gel formulations were visually inspected for 
transparency. 
pH of the edible gel 
pH can influence the stability and taste of the dosage form. Hence, the pH 
of edible gel was measured using digital pH meter by checking the pH of 
a 10 % w/v gel-dispersed in purified water at 25±0.5 °C [11, 14].  
Assay 
Assay was performed by dissolving a known quantity (5 gm) gel in 
distilled water (30 ml) and shaken for 1 hour to get a homogeneous 
solution. The solution was filtered through a 0.45μm filter and 
analyzed at 284 nm using a spectrophotometer after appropriate 
dilutions [15]. 
Syneresis 
Syneresis can be defined as the separation of water by contraction of 
the gel upon standing or during storage. Syneresis is more seen in 
gel formulations with very low concentration of the gelling agent. 
Prepared gel formulations were kept in the refrigerator (4-8 °C) for 
90 d and observed for any signs of syneresis [11, 14, 16]. 
Viscosity and consistency 
Gels formulations were prepared according to the viscosity 
guidelines given by national dysphagia diet task force[3] Viscosity of 
all the gel formulations was measured using Brookfield DV-II+Pro 
viscometer using spindle number LV4 at the rotation of 50 rpm at 
room temperature. The viscosity measurements were made in 
triplicate using fresh samples each time [11]. 
Fourier transform infrared spectroscopy (FTIR) studies 
FTIR studies were performed to find any possible drug-excipient 
interaction by KBr pellet method using Perkin-Elmer 
spectrophotometer, USA (Model-1615). For this study, physical 
mixtures of drug and excipient (1:1) were prepared and co-ground 
with KBr. The resultant mixture was subjected to FTIR studies. Scans 
were performed from 400-4000 cm-1 and an average of 40 scans 
were taken per sample [21]. 
In vitro drug release studies and release kinetics  
In vitro drug release from the gels were studied using USP XXIV 
dissolution apparatus II (Electrolab, Mumbai, India) employing a 
paddle stirrer at 100 rpm using 900 ml of pH 6.8 phosphate buffer at 
37±0.5 °C as a dissolution medium [17]. 5 gm of gel formulation was 
accurately weighed and placed at the bottom of the dissolution 
vessel. Aliquots (5 ml each) were withdrawn at specified time 
intervals (2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 25 and 30 min) and media 
replaced with equal volume each time. The samples were analyzed 
for drug content using UV-Visible spectrophotometer at 284 nm [15, 
22]. The drug release profile was fitted into several mathematical 
models like zero order, first order kinetics, Higuchi and Peppas 
model to get an insight of release mechanism of the drug from the 
dosage form. 
Stability studies 
Optimized gel formulation (F7) was stored in high-density 
polyethene bottles at 25 °C±0.2 °C/60±5 % RH and 40±2 °C/75±5 % 
RH for 3 mo. Samples were withdrawn with 30 d intervals and were 
evaluated for their physical appearance, pH, viscosity, assay and 
drug release [18]. 
RESULTS AND DISCUSSION 
Determination of gelation time 
It was found that formulations F1 to F4 did not form a gel and 
remained in a honey like consistency. Hence, these formulations 
were not considered for further studies.  
Formulations F5 and F6 formed spoon thick gel within 30 min of 
preparation and formulation F7 to F10 formed gel immediately at 
the end of the preparation. Data are shown in table 2. 
 




F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
Gelation time 
(min) 
+ + + + 30 30 ++ ++ ++ ++ 
pH of gel  5.63 5.68 5.58 5.67 5.70 5.75 5.78 5.80 5.68 5.73 
 Syneresis - - - - No No No No No No 
































Very thick Very thick Very thick 
*NS-Non Sticky, NG-Non Gritty, SS-Slightly Sticky, S–Sticky, SG-Slightly Gritty, ‘+‘indicates complete gel has not been formed and consistency 
remained honey like, ‘++’ indicates gel has formed immediately at the end of the preparation. *n=3, mean±SD 
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Appearance and texture evaluation 
All the formulated gels were translucent in appearance. As shown in 
table 2, formulations F1 to F6 were non-sticky and non-gritty. 
Formulations F7 and F8 were slightly sticky and non-gritty. 
Formulations F9 and F10 were sticky and non-gritty in nature as 
determined visually and by mildly rubbing between two fingers. The 
stickiness of gel formulations increased with increase in 
concentration of the polymer.  
pH of the gel and syneresis 
pH and syneresis are interconnected to each other. pH has an 
influence on syneresis. Hence, adjustment of pH plays an important 
role in preventing syneresis. Moreover, pH also has an influence on 
taste of the final formulation [23]. Syneresis is one of the major 
problems associated with gels were a very low concentration of 
gelling agent is used. Formulation F7 to F10 did not show any signs 
of syneresis during storage between 4-8 ᴼC in the refrigerator for 90 
d. Hence, these gel formulations were selected for further studies. 
Slight syneresis was observed in formulations F5 and F6. This could 
be due to low polymer concentration in the formulation. Hence these 
formulations were not considered for further studies. Data shown in 
table 2. 
Assay 
The assay was within 95-105 % of the label claim in all the tested 
formulations.  
Viscosity and consistency 
Normal oral swallowing occurs at a shear rate of 50 s-1 at room 
temperature (perhaps the upper end of the shear rate of 
swallowing) [19]. To date, estimation of lingual shear rates for 
swallowing have been proposed on the basis of perceptual viscosity 
discrimination studies and there is little consensus, with estimates 
ranging from 5 to 1000 s-1 and a value of 50 s-1 most frequently cited 
[20]. All samples were found to be shear thinning that they exhibit a 
reduction in viscosity with increasing shear rate.  
We studied the effect of sodium citrate concentration on viscosity of 
gels formed with increasing amount of polymer. As one may expect, 
there was linear increase in viscosity with increasing polymer 
concentration. However, when we compared viscosities of different 
formulations, there was a significant (P<0.05) difference between 
viscosities of gels formed with 0.5 % w/v gellan gum when different 
concentration of sodium citrate (0.3 and 0.5 % w/v) were used. Data 
depicted in fig. 1. 
 
 
Fig. 1: Effect of sodium citrate concentration (0.3 % and 0.5 
%w/v) on viscosity of EG formulations with increasing gellan 
gum concentration (0.1 % to 0.5 %w/v), n=3, mean±SD 
 
Apparently, sodium citrate provides cations that cause inter and 
intra cross linking of gellan gum’s polymeric chains leading to an 
increase in viscosity [13]. This was not very evident at lower 
polymer concentration because, apparently the amount of cations 
provided by sodium citrate is in far excess. At higher polymer 
concentration, with increase in sodium citrate levels, more inter 
chain cross linking occurs leading to a significant increase in 
viscosity.  
FTIR 
FTIR studies were performed on pure drug and physical mixture of 
the gel formulation. All characteristic peaks of CDL were present in 
their original positions, denoting the absence of drug-excipient 
interaction (fig. 2). 
 
 
Fig. 2: IR-spectrum of pure carvedilol and IR-spectrum of physical mixture of EG formulation. Scans were performed from 400-4000 cm-1. 
average of 40 scans was taken 
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In vitro drug release studies and release kinetics 
The optimized drug formulation (F7) showed over 95 % drug 
release in 12 min (fig. 3). The drug release followed first order 
release kinetics. The value of diffusional exponent ‘n’ suggested that 
both diffusion and matrix erosion contributed to drug release from 
the edible gels. 
Stability 
The optimized edible gel formulations were stored at 25 °C±0.2 °C/60±5 
% RH and 40 °C±0.2 °C/75±5 % RH for a period of 6 and 3 mo 
respectively. It was observed that, gels stored at 40 °C/75 % RH became 
physically unstable. Syneresis was observed in this condition. However, 
no physical/chemical changes were evident in the formulation at 25 °C/ 
60 % RH. The data presented in table 3. 
 
 
Fig. 3: In vitro drug release profile in pH 6.8 buffer for EG formulations F5-F7 and F8-F10 (n=3, mean±3) 
 
Table 3: Stability data of optimized gel formulations stored at 25 °C±0.2 °C/60±5 % RH 
Parameters Time in mo 
0 1 3 
Appearance Translucent Translucent Translucent 
pH 5.78 5.80 5.7 
Assay (%) 96.74±2.31 97.35±1.25 99.32±2.42 
Viscosity (cps)  5907 6049 6231 




In this study, we have made a systematic effort to prepare oral 
edible gel formulation of Carvedilol using gellan gum as gelling 
agent. Based on the consistency, viscosity and release studies, the 
formulation (F7) containing gellan gum (0.4 % w/v) and sodium 
citrate (0.3 % w/v) was optimized. This formulation released 95 % 
of the drug within 12 min. Stability studies of the optimized 
formulation indicated that edible gels are stable when stored 25 
°C/60 % RH. Therefore, from this study, it can be concluded that, 
oral edible gel of carvedilol may prove to be more efficacious in the 
treatment of hypertension particularly in dysphagic patients. 
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